Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thymoma × bosutinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia, Myeloid, Chronic-Phase 4 Philadelphia Chromosome 3 Leukemia 3 Breast Neoplasms 3 Bronchiolitis Obliterans Syndrome 2 Translocation, Genetic 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid 1 Hematologic Diseases 1 Glioblastoma 1 Bone Marrow Diseases 1 Blast Crisis 1 Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

Taxes 2 Sunitinib 2 Paclitaxel 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Carboplatin 2 selinexor 1 saracatinib 1 pembrolizumab 1 epacadostat 1 belinostat 1 amrubicin 1 Thymectomy 1 Robotic Surgical Procedures 1 Ramucirumab 1 Prednisone 1 Prednisolone 1 Pemetrexed 1 MK 2206 1 Lapatinib 1 Fentanyl 1 Erlotinib Hydrochloride 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡